Penserra Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-45
Closed -$8K 1541
2021
Q3
$8K Hold
45
﹤0.01% 1382
2021
Q2
$7K Buy
45
+1
+2% +$156 ﹤0.01% 1298
2021
Q1
$8K Hold
44
﹤0.01% 1059
2020
Q4
$8K Buy
44
+29
+193% +$5.27K ﹤0.01% 948
2020
Q3
$2K Buy
+15
New +$2K ﹤0.01% 909